The role of isoniazid dosage and NAT2 gene polymorphism in the treatment of tuberculous meningitis
BackgroundTuberculous meningitis (TBM) is a non-purulent inflammatory condition affecting the meninges and spinal membranes, caused by Mycobacterium tuberculosis (MTB) infection. This study seeks to explore the impact of varying INH dosages and NAT2 gene polymorphisms on TBM treatment, contributing...
Saved in:
| Main Authors: | Yi Jian, Yuhang Bao, Fashuang Yang, Mei Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1535447/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
One-year mortality of tuberculosis patients on isoniazid-based treatment and its association with rapid acetylator NAT2 genotypes
by: Ayu Kasamatsu, et al.
Published: (2025-06-01) -
Chronic Neutrophilic Meningitis in Tuberculous Infection: A Rare Case Presentation and review of the literature
by: Amanj Jamal Pastaksor, et al.
Published: (2024-12-01) -
Development and validation of a diagnostic model for tuberculous meningitis based on laboratory data
by: Fuyong Liu, et al.
Published: (2025-05-01) -
Features tuberculous etiology meningitis in young children
by: O. V. Kolokolova, et al.
Published: (2012-12-01) -
Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis
by: Rashmi Mahajan, et al.
Published: (2024-12-01)